Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar-Apr;38(4Part-II):922-927.
doi: 10.12669/pjms.38.4.4835.

Effect of bronchofiberscopic lavage with budesonide suspension on refractory mycoplasma pneumoniae pneumonia

Ya Li  1 , Wei Yang  2 , Xin Wu  3 , Xiaohua Gou  4
Affiliations

Effect of bronchofiberscopic lavage with budesonide suspension on refractory mycoplasma pneumoniae pneumonia

Ya Li et al. Pak J Med Sci. 2022 Mar-Apr.

Abstract

Objectives: To investigate the clinical efficacy of budesonide suspension through bronchofiberscopic lavage in the treatment of refractory mycoplasma pneumoniae pneumonia.(RMPP).

Methods: A total of 108 children with refractory mycoplasma pneumoniae pneumonia from June 2018 to October 2020 were randomly divided into two groups: the study group and the control group, with 54 cases in each group. Children in the control group were treated with anti-infective, antitussive, antipyretic routine symptomatic treatment and nebulization of budesonide suspension, while children in the study group were treated with bronchofiberscopic lavage with Budesonide suspension along with standard treatment as in control group. The clinical efficacy, changes in blood gas analysis indexes, levels of inflammatory mediators, time for improvement of clinical symptoms and the incidence of adverse reactions were compared between the two groups.

Results: The efficacy of treatment in the study group was 85.19%, which was higher than 66.67% in the control group (P<0.05). The antipyretic time, antitussive time, lung rales disappearance time and length of hospital stay in the study group were shorter than those in the control group (P<0.05). Moreover, the levels of arterial oxygen partial pressure (PaO2) in the study group were higher than those in the control group, while the levels of partial pressure of carbon dioxide (PaCO2) and arterial oxygen saturation (SaO2) in the study group were lower than those in the control group (P<0.05). The levels of inflammatory mediators interleukin-6 (IL-6), interleukin-4 (IL-4), and interferon-γ (IFN-γ) in the study group were lower than those in the control group (P<0.05), and no significant difference was found in the comparison of the incidence of adverse reactions between the two groups (P>0.05).

Conclusions: Budesonide suspension combined with bronchofiberscopic lavage with Budesonide suspension is a safe treatment regimen that can significantly improve the clinical outcome in children with RMPP. With such a combined treatment regimen, the clinical symptoms of children can be ameliorated, the ventilation function can be enhanced, and the level of inflammatory mediators will be reduced.

Keywords: bronchofiberscopic lavage; budesonide suspension; mycoplasma pneumonia; refractory pneumonia.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None

References

    1. Lee E, Young Lee Y. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance. Respir Med. 2020;175:106209. doi:10.1016/j.rmed.2020.106209. - PubMed
    1. Wang Z, Yang L, Ye J, Wang Y, Liu Y. Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia. Immunol Res. 2019;67(4-5):373–381. doi:10.1007/s12026-019-09096-6. - PubMed
    1. Lan Y, Li S, Yang D, Zhou J, Wang Y, Wang J, et al. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia:A retrospective study. Medicine (Baltimore) 2020;99(19):e19987. doi:10.1097/MD.0000000000019987. - PMC - PubMed
    1. Qiu JL, Huang L, Shao MY, Chai YN, Zhang HJ, Li XF, et al. Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children:A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2020;99(22):e20121. doi:10.1097/MD.0000000000020121. - PMC - PubMed
    1. Wang L, Wang W, Sun JM, Ni SW, Ding JL, Zhu YL, et al. Efficacy of fiberoptic bronchoscopy and bronchoalveolar lavage in childhood-onset, complicated plastic bronchitis. Pediatr Pulmonol. 2020;55(11):3088–3095. doi:10.1002/ppul.25016. - PubMed

LinkOut - more resources